Amplyx Adds Cash from Pfizer, Adage as Funding Round Tops $90M
Xconomy
MAY 19, 2020
Amplyx Pharmaceuticals has completed enrollment in one mid-stage trial of its lead drug candidate, a new kind of antifungal treatment, and has finished treating the first patients in two more such studies.
Let's personalize your content